Amgen Inc's new monoclonal antibody Prolia (denosumab) is the first "biologic therapy" approved by the FDA for the treatment of osteoporosis in menopausal women.
Santa Maria Young II, PharmD Candidate
Advertisement
Articles by Santa Maria Young II, PharmD Candidate
Advertisement
Latest Updated Articles
- A Closer Look at New FDA Actions: Amgen's Prolia
Published: August 17th 2010 | Updated:
Advertisement
Advertisement
